ArticleChest2020
Place of Death for Individuals With Chronic Lung Disease: Trends and Associated Factors From 2003 to 2017 in the United States.
Article in Chest, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis.Palliative medicine · 2022Pooled it
- "It Felt Like Throwing in the Towel": Family Caregiver Perspectives on End-of-Life Decision Making in Chronic Obstructive Pulmonary Disease.Journal of palliative medicine · 2026Article
- The inverse palliative care law in advanced lung disease: a mixed-methods systematic review and meta-analysis.EClinicalMedicine · 2026Article
- Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave.BMC infectious diseases · 2025Article
- Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease.Respiratory medicine · 2024Article
- Costs of End-of-Life Hospitalizations in the United States for People With Pulmonary Diseases.Chest · 2024Article
- Developing a generic business case for an advanced chronic liver disease support service.Frontline gastroenterology · 2024Article
- Lung Ultrasound Assessment of Lung Hyperinflation in Patients with Stable COPD: An Effective Diagnostic Tool.International journal of chronic obstructive pulmonary disease · 2024Article
- An 8-year observational study of the death places of patients with COPD in Turkey.Geriatrics & gerontology international · 2023Observational
- Place of death among individuals with chronic respiratory diseases in China: Trends and associated factors between 2014 and 2020.Frontiers in public health · 2023Article
- Availability of family care resources, type of primary caregiving and home death among the oldest-old: A population-based retrospective cohort study in China.SSM - population health · 2022Article
- Two-dimensional shear wave elastography: a new tool for evaluating respiratory muscle stiffness in chronic obstructive pulmonary disease patients.BMC pulmonary medicine · 2022Article
- Where Are We Dying? Ethnic Differences in Place of Death Among New Zealanders Dying of Cancer.JCO global oncology · 2022Article
- Trends and associated factors in place of death among individuals with cardiovascular disease in China, 2008-2020: A population-based study.The Lancet regional health. Western Pacific · 2022Article
- Illnesses and Symptoms in Older Adults at the End of Life at Different Places of Death in Korea.International journal of environmental research and public health · 2022Article
- Where Do Chronic Obstructive Pulmonary Disease Patients Die? 8-Year Trend, with Special Focus on Sex-Related Differences.International journal of chronic obstructive pulmonary disease · 2022Article
- Changes in the place of death for older adults with cancer: Reason to celebrate or a risk for unintended disparities?Journal of geriatric oncology · 2021Article
- Trends in Location of Death Among Older Adult Americans After Falls.Gerontology & geriatric medicineArticle
Corrections and comments
- Commented on by
Authors and funding
5 authors at 5 institutions in 1 country.
Funding
Abstract
backgroundAlthough chronic lung disease is a common cause of mortality, little is known about where individuals with chronic lung disease die. RESEARCH QUESTION: The aim of this study was to determine the trends and factors associated with place of death among individuals with chronic lung disease. STUDY DESIGN AND
methodsThis cross-sectional analysis of natural deaths was conducted by using the Centers for Disease Control and Prevention Wide-ranging OnLine Data for Epidemiologic Research from 2003 to 2017 for which COPD, interstitial lung disease (ILD), or cystic fibrosis (CF) was the underlying cause. Place of death was categorized as hospital, home, nursing facility, hospice facility, and other.
resultsFrom 2003 to 2017, more than 2.2. million deaths were primarily attributed to chronic lung disease (51.6% female, 92.4% white). Most were attributed to COPD (88.9%), followed by ILD (10.8.%), and CF (0.3%). Hospital and nursing facility deaths declined from 44.4% (n = 59,470) and 22.6% (n = 30,285) to 28.3% (n = 49,655) and 19.7% (n = 34,495), while home and hospice facility deaths increased from 23.3% (n = 31,296) and 0.1% (n = 192) to 34.7% (n = 60,851) and 9.0% (n = 15,861), respectively. Male sex, being married, and having some college education were associated with increased odds of home death, whereas non-white race and Hispanic ethnicity were associated with increased odds of hospital death. Compared with individuals with COPD, individuals with ILD and CF had increased odds of hospital death and reduced odds of home, nursing facility, or hospice facility death.
interpretationHome deaths are rising among decedents from chronic lung disease, increasing the need for quality end-of-life care in this setting. Further research should explore the end-of-life needs and preferences of these patients and their caregivers, with particular attention paid to patients with ILD and CF who continue to have high rates of hospital death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.